Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AIF1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SFT2D3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCS1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP2A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAUS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABLIM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNPO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCCIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PYGL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DGAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDH7A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on